Stayble Therapeutics AB (publ) (STO: STABL)
Sweden
· Delayed Price · Currency is SEK
0.410
+0.012 (3.02%)
Dec 23, 2024, 5:21 PM CET
Stayble Therapeutics AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Cash & Equivalents | 3.59 | 14.08 | 12.85 | 37.47 | 10.87 | 3.82 | Upgrade
|
Cash & Short-Term Investments | 3.59 | 14.08 | 12.85 | 37.47 | 10.87 | 3.82 | Upgrade
|
Cash Growth | -83.12% | 9.60% | -65.71% | 244.77% | 184.28% | 26.02% | Upgrade
|
Other Receivables | 0.27 | 0.32 | 0.61 | 0.45 | 0.35 | 0.22 | Upgrade
|
Receivables | 0.27 | 0.32 | 0.61 | 0.45 | 0.35 | 0.22 | Upgrade
|
Prepaid Expenses | 1.91 | 0.02 | 0.04 | 0.08 | 0.03 | 0.03 | Upgrade
|
Other Current Assets | - | 1.64 | - | - | 1.1 | - | Upgrade
|
Total Current Assets | 5.77 | 16.05 | 13.5 | 37.99 | 12.35 | 4.07 | Upgrade
|
Long-Term Investments | - | - | - | 0 | - | - | Upgrade
|
Long-Term Deferred Charges | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 | Upgrade
|
Total Assets | 11.42 | 21.7 | 19.15 | 43.64 | 18 | 9.72 | Upgrade
|
Accounts Payable | 0.35 | 2.55 | 1.04 | 0.43 | 0.72 | 0.65 | Upgrade
|
Accrued Expenses | 0.27 | 1.56 | 1.82 | 2.2 | 0.39 | 0.91 | Upgrade
|
Other Current Liabilities | 0.06 | 0.23 | 0.15 | 0.35 | 0.29 | 7.1 | Upgrade
|
Total Current Liabilities | 0.68 | 4.34 | 3.02 | 2.98 | 1.4 | 8.66 | Upgrade
|
Long-Term Debt | 0.85 | 0.85 | 0.85 | 0.85 | 1.04 | 1.35 | Upgrade
|
Total Liabilities | 1.53 | 5.19 | 3.87 | 3.83 | 2.45 | 10.01 | Upgrade
|
Common Stock | 5.68 | 4.12 | 1.8 | 1.8 | 0.9 | 0.53 | Upgrade
|
Additional Paid-In Capital | 35.42 | 34.2 | 36.08 | 48.18 | 30.96 | 5.09 | Upgrade
|
Retained Earnings | -33.14 | -23.74 | -24.53 | -12.09 | -18.23 | -7.84 | Upgrade
|
Comprehensive Income & Other | 1.92 | 1.92 | 1.92 | 1.92 | 1.92 | 1.92 | Upgrade
|
Shareholders' Equity | 9.89 | 16.51 | 15.28 | 39.81 | 15.55 | -0.3 | Upgrade
|
Total Liabilities & Equity | 11.42 | 21.7 | 19.15 | 43.64 | 18 | 9.72 | Upgrade
|
Total Debt | 0.85 | 0.85 | 0.85 | 0.85 | 1.04 | 1.35 | Upgrade
|
Net Cash (Debt) | 2.74 | 13.23 | 12 | 36.62 | 9.82 | 2.47 | Upgrade
|
Net Cash Growth | -86.58% | 10.28% | -67.24% | 272.78% | 297.24% | 13.25% | Upgrade
|
Net Cash Per Share | - | 0.51 | 0.87 | 2.64 | 1.42 | 0.61 | Upgrade
|
Filing Date Shares Outstanding | - | 31.72 | 13.85 | 13.85 | 6.92 | 4.07 | Upgrade
|
Total Common Shares Outstanding | - | 31.72 | 13.85 | 13.85 | 6.92 | 4.07 | Upgrade
|
Working Capital | 5.09 | 11.71 | 10.48 | 35.01 | 10.94 | -4.59 | Upgrade
|
Book Value Per Share | - | 0.52 | 1.10 | 2.87 | 2.25 | -0.07 | Upgrade
|
Tangible Book Value | 9.89 | 16.51 | 15.28 | 39.81 | 15.55 | -0.3 | Upgrade
|
Tangible Book Value Per Share | - | 0.52 | 1.10 | 2.87 | 2.25 | -0.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.